Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer

BACKGROUND: In clinically node-negative breast cancer patients, the INSEMA trial (NCT02466737) assessed the non-inferiority of avoiding sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND). Here we present patient-reported outcomes (PROs) as a secondary endpoint. METHODS: PROs...

Descripción completa

Detalles Bibliográficos
Autores principales: Reimer, Toralf, Stachs, Angrit, Veselinovic, Kristina, Polata, Silke, Müller, Thomas, Kühn, Thorsten, Heil, Jörg, Ataseven, Beyhan, Reitsamer, Roland, Hildebrandt, Guido, Knauer, Michael, Golatta, Michael, Stefek, Andrea, Zahm, Dirk-Michael, Thill, Marc, Nekljudova, Valentina, Krug, David, Loibl, Sibylle, Gerber, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706517/
https://www.ncbi.nlm.nih.gov/pubmed/36457648
http://dx.doi.org/10.1016/j.eclinm.2022.101756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706517/
https://www.ncbi.nlm.nih.gov/pubmed/36457648
http://dx.doi.org/10.1016/j.eclinm.2022.101756

Ejemplares similares